Alembic Pharmaceuticals Limited — Updates, 13-09-2025: General Updates
13-09-2025 | 03:52 pm
13-09-2025 | 03:52 pm
Alembic Pharma secured an USFDA Establishment Inspection Report (EIR) for its Panelav API-I & API-II facilities. This signifies a positive closure of the inspection, crucial for its US market operations.
No comments yet. Be the first to comment!
